These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
429 related articles for article (PubMed ID: 32347951)
1. Association of Rare Pathogenic DNA Variants for Familial Hypercholesterolemia, Hereditary Breast and Ovarian Cancer Syndrome, and Lynch Syndrome With Disease Risk in Adults According to Family History. Patel AP; Wang M; Fahed AC; Mason-Suares H; Brockman D; Pelletier R; Amr S; Machini K; Hawley M; Witkowski L; Koch C; Philippakis A; Cassa CA; Ellinor PT; Kathiresan S; Ng K; Lebo M; Khera AV JAMA Netw Open; 2020 Apr; 3(4):e203959. PubMed ID: 32347951 [TBL] [Abstract][Full Text] [Related]
2. Association of the Interaction Between Familial Hypercholesterolemia Variants and Adherence to a Healthy Lifestyle With Risk of Coronary Artery Disease. Fahed AC; Wang M; Patel AP; Ajufo E; Maamari DJ; Aragam KG; Brockman DG; Vosburg T; Ellinor PT; Ng K; Khera AV JAMA Netw Open; 2022 Mar; 5(3):e222687. PubMed ID: 35294538 [TBL] [Abstract][Full Text] [Related]
3. Population genetic screening efficiently identifies carriers of autosomal dominant diseases. Grzymski JJ; Elhanan G; Morales Rosado JA; Smith E; Schlauch KA; Read R; Rowan C; Slotnick N; Dabe S; Metcalf WJ; Lipp B; Reed H; Sharma L; Levin E; Kao J; Rashkin M; Bowes J; Dunaway K; Slonim A; Washington N; Ferber M; Bolze A; Lu JT Nat Med; 2020 Aug; 26(8):1235-1239. PubMed ID: 32719484 [TBL] [Abstract][Full Text] [Related]
4. Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study. International Mismatch Repair Consortium Lancet Oncol; 2021 Jul; 22(7):1014-1022. PubMed ID: 34111421 [TBL] [Abstract][Full Text] [Related]
5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of a genomic screening program for actionable genetic conditions. Buchanan AH; Lester Kirchner H; Schwartz MLB; Kelly MA; Schmidlen T; Jones LK; Hallquist MLG; Rocha H; Betts M; Schwiter R; Butry L; Lazzeri AL; Frisbie LR; Rahm AK; Hao J; Willard HF; Martin CL; Ledbetter DH; Williams MS; Sturm AC Genet Med; 2020 Nov; 22(11):1874-1882. PubMed ID: 32601386 [TBL] [Abstract][Full Text] [Related]
7. Metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after extensive versus partial colectomy in the Netherlands: a retrospective cohort study. Eikenboom EL; Moen S; van Leerdam ME; Papageorgiou G; Doukas M; Tanis PJ; Dekker E; Wagner A; Spaander MCW; Lancet Gastroenterol Hepatol; 2023 Dec; 8(12):1106-1117. PubMed ID: 37865103 [TBL] [Abstract][Full Text] [Related]
8. Gene Sequencing for Pathogenic Variants Among Adults With Breast and Ovarian Cancer in the Caribbean. George SHL; Donenberg T; Alexis C; DeGennaro V; Dyer H; Yin S; Ali J; Butler R; Chin SN; Curling D; Lowe D; Lunn J; Turnquest T; Wharfe G; Cerbon D; Barreto-Coelho P; Schlumbrecht MP; Akbari MR; Narod SA; Hurley JE JAMA Netw Open; 2021 Mar; 4(3):e210307. PubMed ID: 33646313 [TBL] [Abstract][Full Text] [Related]
9. Association of Pathogenic DNA Variants Predisposing to Cardiomyopathy With Cardiovascular Disease Outcomes and All-Cause Mortality. Patel AP; Dron JS; Wang M; Pirruccello JP; Ng K; Natarajan P; Lebo M; Ellinor PT; Aragam KG; Khera AV JAMA Cardiol; 2022 Jul; 7(7):723-732. PubMed ID: 35544052 [TBL] [Abstract][Full Text] [Related]
11. Targeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes. Brandão RD; Mensaert K; López-Perolio I; Tserpelis D; Xenakis M; Lattimore V; Walker LC; Kvist A; Vega A; Gutiérrez-Enríquez S; Díez O; ; de la Hoya M; Spurdle AB; De Meyer T; Blok MJ Int J Cancer; 2019 Jul; 145(2):401-414. PubMed ID: 30623411 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer. Vietri MT; D'Elia G; Caliendo G; Casamassimi A; Federico A; Passariello L; Cioffi M; Molinari AM Med Oncol; 2021 Jan; 38(2):13. PubMed ID: 33484353 [TBL] [Abstract][Full Text] [Related]
13. The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice. Menko FH; Ter Stege JA; van der Kolk LE; Jeanson KN; Schats W; Moha DA; Bleiker EMA Fam Cancer; 2019 Jan; 18(1):127-135. PubMed ID: 29846880 [TBL] [Abstract][Full Text] [Related]
14. ABCG5 and ABCG8 genetic variants in familial hypercholesterolemia. Reeskamp LF; Volta A; Zuurbier L; Defesche JC; Hovingh GK; Grefhorst A J Clin Lipidol; 2020; 14(2):207-217.e7. PubMed ID: 32088153 [TBL] [Abstract][Full Text] [Related]
15. Clinical Factors Associated with Urinary Tract Cancer in Individuals with Lynch Syndrome. Wischhusen JW; Ukaegbu C; Dhingra TG; Uno H; Kastrinos F; Syngal S; Yurgelun MB Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):193-199. PubMed ID: 31615790 [TBL] [Abstract][Full Text] [Related]
16. Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers. Park DJ; Tao K; Le Calvez-Kelm F; Nguyen-Dumont T; Robinot N; Hammet F; Odefrey F; Tsimiklis H; Teo ZL; Thingholm LB; Young EL; Voegele C; Lonie A; Pope BJ; Roane TC; Bell R; Hu H; Shankaracharya ; Huff CD; Ellis J; Li J; Makunin IV; John EM; Andrulis IL; Terry MB; Daly M; Buys SS; Snyder C; Lynch HT; Devilee P; Giles GG; Hopper JL; Feng BJ; Lesueur F; Tavtigian SV; Southey MC; Goldgar DE Cancer Discov; 2014 Jul; 4(7):804-15. PubMed ID: 25050558 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of genetic susceptibility for breast and ovarian cancer in a non-cancer related study population: secondary germline findings from a Swiss single centre cohort. Kraemer D; Azzarello-Burri S; Steindl K; Boonsawat P; Zweier M; Dedes KJ; Joset P; Fink D; Rauch A Swiss Med Wkly; 2019 Aug; 149():w20092. PubMed ID: 31422574 [TBL] [Abstract][Full Text] [Related]
19. Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibility. Rowley SM; Mascarenhas L; Devereux L; Li N; Amarasinghe KC; Zethoven M; Lee JEA; Lewis A; Morgan JA; Limb S; Young MA; James PA; Trainer AH; Campbell IG Genet Med; 2019 Apr; 21(4):913-922. PubMed ID: 30254378 [TBL] [Abstract][Full Text] [Related]
20. Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies. Ryan NAJ; Morris J; Green K; Lalloo F; Woodward ER; Hill J; Crosbie EJ; Evans DG JAMA Oncol; 2017 Dec; 3(12):1702-1706. PubMed ID: 28772289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]